Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marston Linehan

Showing results (451-460 of 487) with videos related to

Pageof 49
Sort By:
Nature Structural & Molecular Biology|August 12, 2021
The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effectMark R Woodford, Alexander J Baker-Williams, Rebecca A Sager, et al.
European Urology Oncology|April 13, 2021
Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio StudyMichael Ahdoot, Amir H Lebastchi, Lori Long, et al.
The Journal of Clinical Investigation|September 24, 2020
Tobacco smoking induces metabolic reprogramming of renal cell carcinomaJames Reigle, Dina Secic, Jacek Biesiada, et al.
Human Molecular Genetics|May 17, 2018
BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genesHisashi Hasumi, Mitsuko Furuya, Kenji Tatsuno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinomaToni K Choueiri, Ulka Vaishampayan, Jonathan E Rosenberg, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Oncotarget|September 30, 2016
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutationSuraj Peri, Elena Caretti, Rossella Tricarico, et al.
International Journal of Cancer|November 15, 2012
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studiesMark P Purdue, Lee E Moore, Maria J Merino, et al.
Cancer Research|July 20, 2006
Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinomaJoseph Riss, Chand Khanna, Seongjoon Koo, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
Pageof 49

Showing results (451-460 of 487) with videos related to

Sort By:
Pageof 49
Nature Structural & Molecular Biology|August 12, 2021
The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effectMark R Woodford, Alexander J Baker-Williams, Rebecca A Sager, et al.
European Urology Oncology|April 13, 2021
Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio StudyMichael Ahdoot, Amir H Lebastchi, Lori Long, et al.
The Journal of Clinical Investigation|September 24, 2020
Tobacco smoking induces metabolic reprogramming of renal cell carcinomaJames Reigle, Dina Secic, Jacek Biesiada, et al.
Human Molecular Genetics|May 17, 2018
BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genesHisashi Hasumi, Mitsuko Furuya, Kenji Tatsuno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinomaToni K Choueiri, Ulka Vaishampayan, Jonathan E Rosenberg, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Oncotarget|September 30, 2016
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutationSuraj Peri, Elena Caretti, Rossella Tricarico, et al.
International Journal of Cancer|November 15, 2012
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studiesMark P Purdue, Lee E Moore, Maria J Merino, et al.
Cancer Research|July 20, 2006
Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinomaJoseph Riss, Chand Khanna, Seongjoon Koo, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
Pageof 49